Skip to main content
PredictPedia
K

Medtronic cardiovascular growth in Q2

91%
Trade
Event Group
EventKALSHI

Medtronic cardiovascular growth in Q2

Medtronic cardiovascular growth in Q2
Yes

91%

|
Vol

$7.15K

|
Markets

9

Trade

Market Price Graph

9 markets tracked

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

kalshi

No data available

All Markets(9)
MarketPrice
Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?
91%
Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?
76%
Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?
55%
Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?
41%
Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?
31%

Markets (9)

Sort
KALSHICompanies
Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 8% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome90.5%
Yes
Volume$252.00
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 9% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 9% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome75.5%
Yes
Volume$1.15K
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 10% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome55.0%
Yes
Volume$0.00
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 10.5% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 10.5% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand nam

Health Score25/100
Yes Outcome41.0%
Yes
Volume$14.00
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 11% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 11% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome31.0%
Yes
Volume$605.01
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 11.5% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 11.5% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 11.5% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand nam

Health Score25/100
Yes Outcome25.0%
Yes
Volume$962.09
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 12% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 12% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 12% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome22.0%
Yes
Volume$1.49K
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 13% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 13% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 13% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome15.0%
Yes
Volume$1.55K
LiquidityN/A
End DateMar 31, 2027
View Details
KALSHICompanies
Will Medtronic plc report Above 14% cardiovascular organic revenue growth in Q2 2027?

Will Medtronic plc report Above 14% cardiovascular organic revenue growth in Q2 2027?

If Medtronic plc reports Above 14% cardiovascular organic revenue growth in Q2 2027, then the market resolves to Yes. Secondary rules: Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names

Health Score25/100
Yes Outcome4.5%
Yes
Volume$1.12K
LiquidityN/A
End DateMar 31, 2027
View Details

Share This Event

Share on social media or embed on your website

Back to Event Group